Company intelligence / Profile preview
Bio-Technology General
Beer Tuvia, Southern District, Israelbtgil.com ↗
- Ownership
- Private
- Employees
- ~400
- Development stage
- Commercial
01
Overview
Bio-Technology General is an integrated biopharmaceutical company specializing in the research, development, and manufacturing of innovative biopharmaceutical products derived from genetic engineering. It has developed and commercialized several recombinant protein therapeutics including human growth hormone and other biologics. The company operates as a Center for Excellence in Biotechnology within Ferring Pharmaceuticals’ global network.
- Therapeutic areas
- EndocrinologyRheumatologyOphthalmologyInfectious Diseases
- Modalities
- Recombinant proteinProteinBiologic
- Industry
- Biotech
02
Drug pipeline
12 assets11 more assets in the full pipeline.
03
Partnerships
JCR Pharmaceuticals (human growth hormone)Pharmacia (NaHA development)American Cyanamid (bovine growth hormone)
Beyond the preview
Go deeper on Bio-Technology General.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bio-Technology General.